Frontlight ResearchEarly access
Trial site
Pectus Respiratory Health S.L.
- 8running trials
- 1closed trial
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Asthma5 trials
- COPD2 trials
- Bronchiectasis1 trial
- Cystic fibrosis1 trial
- Idiopathic pulmonary fibrosis1 trial
- Phase
- Phase 25 trials
- Phase 33 trials
- Phase 41 trial
- Status
- Recruiting4 trials
- Not yet recruiting3 trials
- Active, not recruiting1 trial
- Completed1 trial
- Lead sponsor
- Sanofi3 trials
- LETI Pharma S.L.U.2 trials
- Agomab Spain S.L.U.1 trial
- GlaxoSmithKline1 trial
- Regeneron Pharmaceuticals1 trial
- and 1 more
Running trials
Not yet recruiting
A Phase 2 trial of AGMB-447 in participants with idiopathic pulmonary fibrosis
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Asthma4 recruiting
- COPD2 recruiting
- Idiopathic pulmonary fibrosis1 recruiting
Closed trials
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026